These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 23881265)

  • 1. Systemic involvements and preferred treatments in a large cohort of Behçet's disease.
    Yilmaz S; Karadag O; Yazisiz V; Altun B; Gezer M; Karaman M; Cinar M; Erdem H; Pay S; Dinc A
    Rheumatol Int; 2013 Dec; 33(12):3025-30. PubMed ID: 23881265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacotherapy for Behcet's syndrome.
    Saenz A; Ausejo M; Shea B; Wells G; Welch V; Tugwell P
    Cochrane Database Syst Rev; 2000; 1998(2):CD001084. PubMed ID: 10796413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical profiling, treatment characteristics and outcome in Behcet's Disease (BD)-A retrospective cohort study from Karnataka Rheumatology Association (KRA).
    Rao VK; Kodali RS; Patil A; Chebbi P; Subramanian R; Kumar S; Singh YP; Chandrashekara S; Shobha V
    Clin Rheumatol; 2024 Oct; 43(10):3223-3230. PubMed ID: 39096360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Juvenile Behçet's disease: a tertiary center experience.
    Ekici Tekin Z; Çelikel E; Aydin F; Kurt T; Sezer M; Tekgöz N; Karagöl C; Coşkun S; Kaplan MM; Çelikel Acar B
    Clin Rheumatol; 2022 Jan; 41(1):187-194. PubMed ID: 34476647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy for Behçet's disease.
    Mochizuki M
    Int Rev Immunol; 1997; 14(1):49-66. PubMed ID: 9203026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on the treatment of Behçet's syndrome.
    Esatoglu SN; Hatemi G
    Intern Emerg Med; 2019 Aug; 14(5):661-675. PubMed ID: 30684097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behçet's disease in Lebanon: report of 100 cases.
    Ghayad E; Tohme A
    J Med Liban; 1995; 43(1):2-7. PubMed ID: 8676358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Behçet's disease.
    Bang D
    Yonsei Med J; 1997 Dec; 38(6):401-10. PubMed ID: 9509910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical manifestations and anti-TNF alpha therapy of juvenile Behçet's disease in Taiwan.
    Hu YC; Yang YH; Lin YT; Wang LC; Yu HH; Lee JH; Chiang BL
    BMC Pediatr; 2019 Jul; 19(1):232. PubMed ID: 31296171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practical treatment recommendations for pharmacotherapy of Behçet's syndrome.
    Yazici H; Barnes CG
    Drugs; 1991 Nov; 42(5):796-804. PubMed ID: 1723375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of ultrasound biomicroscopy, indocyanine green angiography and HLA-B51 testing as adjunct methods in the appraisal of Behçet's uveitis.
    Klaeger AJ; Tran VT; Hiroz CA; Morisod L; Herbort CP
    Int Ophthalmol; 2004 Jan; 25(1):57-63. PubMed ID: 15085978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Could nicotine be beneficial for Behçet's disease?
    Kaklamani VG; Markomichelakis N; Kaklamanis PG
    Clin Rheumatol; 2002 Aug; 21(4):341-2. PubMed ID: 12296287
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of Behçet's disease--an update.
    Kaklamani VG; Kaklamanis PG
    Semin Arthritis Rheum; 2001 Apr; 30(5):299-312. PubMed ID: 11303303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A national cohort study on pediatric Behçet's disease: cross-sectional data from an Italian registry.
    Gallizzi R; Pidone C; Cantarini L; Finetti M; Cattalini M; Filocamo G; Insalaco A; Rigante D; Consolini R; Maggio MC; Civino A; Martino S; Olivieri AN; Fabio G; Pastore S; Mauro A; Sutera D; Trimarchi G; Ruperto N; Gattorno M; Cimaz R
    Pediatr Rheumatol Online J; 2017 Dec; 15(1):84. PubMed ID: 29268757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current therapy for Behçet's disease.
    Goker B; Goker H
    Am J Ther; 2002; 9(5):465-70. PubMed ID: 12237740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behçet's disease with relapsing cutaneous polyarteritis-nodosa-like lesions, responsive to oral cyclosporine therapy.
    Vikas A; Atul S; Singh R; Sarbmeet L; Mohan H
    Dermatol Online J; 2003 Dec; 9(5):9. PubMed ID: 14996382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporine and therapeutic plasma exchange in treatment of progressive autoimmune diseases.
    Schiel R; Bambauer R; Latza R; Klinkmann J
    Artif Organs; 1997 Sep; 21(9):983-8. PubMed ID: 9288868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel approaches to Behçet's disease.
    Sakane T; Takeno M
    Expert Opin Investig Drugs; 2000 Sep; 9(9):1993-2005. PubMed ID: 11060788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole thoracal spinal cord involvement in case of neuro-Behçet's disease.
    Kabukçu T; Edemci S; Uçan H; Celik C; Gunes HN; Yoldas T
    Rheumatol Int; 2009 Apr; 29(6):707-9. PubMed ID: 18982328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behçet's syndrome: from aetiology to treatment.
    Powell RJ
    Adv Exp Med Biol; 2003; 528():481-6. PubMed ID: 12918749
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.